Title:
【発明の名称】プロゲスチン/エストロゲンからなる第一相とプロゲスチンからなる第二相とを有する経口避妊薬製剤
Document Type and Number:
Japanese Patent JP2001516720
Kind Code:
A
Abstract:
This invention provides a method of contraception which comprises administering to a female of child bearing age for 28 days per menstrual cycle a combination of a progestin at a daily dosage equivalent to 30-150 mu g levornorgestrel and an estrogen at a daily dosage equivalent to 10-20 mu g ethinyl estradiol for 23-25 days beginning on day 1 of the menstrual cycle, followed by administering a progestin at a daily dosage equivalent to 10-100 mu g levornorgestrel for 3-5 days.
More Like This:
| WO/2004/000361 | METASTABLE PHARMACEUTICAL COMPOSITIONS |
| WO/1996/035427 | TRANSDERMAL THERAPEUTIC SYSTEM FOR ADMINISTERING TESTOSTERONE |
Inventors:
Michael Jay Gast
Application Number:
JP2000511503A
Publication Date:
October 02, 2001
Filing Date:
September 09, 1998
Export Citation:
Assignee:
American Home Products Corporation
International Classes:
A61K31/565; A61K31/57; A61P15/18; (IPC1-7): A61K31/565; A61K31/57; A61P15/18
Attorney, Agent or Firm:
Aoyama Ryo (1 person outside)